StockrabitBrowse analysts
Analyst questions

Gautami Agarwal

Firm not listed in source transcripts
ONESOURCE

Onesource Specialty Pharma Limited

All company calls
Onesource Specialty Pharma Limited
25 Jul 2026
Open call
  1. Hello, sir. So, we know about your FY28 guidance of US D160 million EBITDA. But can you highlight few initiatives you are taking for a longer term, which is beyond FY28? So, if we model for FY29 -30 for OneSource, do we think of growth trajectory longer term on 28 basis remains intact or otherwise? Can you give some clarity on that bit?

    Read in transcript
  2. Okay, okay, sir. Thank you. That perfectly answered my question. Thank you.

    Read in transcript